Strides Pharma Science Ltd.

BSE: 532531 | NSE: STAR |

Represents Equity.Intra - day transactions are permissible and normal trading is done in this category

Series: EQ | ISIN: INE939A01011 | SECTOR: Pharmaceuticals & DrugsPharmaceuticals & Drugs

Success

Alert

Please select a Day.

Info

Open trading A/c Open trading A/c

Strides Pharma Strides Pharma Science Ltd. | BSE 857.35 -8.25 (-0.95%) | NSE 857.65 -8.10 (-0.94%) | Trade | Add

BSE Live

Feb 13, 16:01

857.35 -8.25 (-0.95%)

Volume

AVERAGE VOLUME

5-Day

6,241

10-Day

10,966

30-Day

27,343

4,207

Prev. Close

865.60
Open Price

860.30

Bid Price (Qty.)
845.30 (1)
Offer Price (Qty.)
875.70 (20)

NSE Live

Feb 13, 15:58

857.65 -8.10 (-0.94%)

Volume

AVERAGE VOLUME

5-Day

219,880

10-Day

295,252

30-Day

537,136

180,227

Prev. Close

865.75
Open Price

867.00

Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
857.65 (27)

Financials

Print/Copy to Excel : Go

Balance Sheet of Strides Pharma Science (in Rs. Cr.)	Mar 20	Mar 19	Mar 18	Mar 17	Mar 16
	12 mths	12 mths	12 mths	12 mths	12 mths
EQUITIES AND LIABILITIES
SHAREHOLDER'S FUNDS
Equity Share Capital	89.57	89.55	89.50	89.42	89.35
Total Share Capital	89.57	89.55	89.50	89.42	89.35
Reserves and Surplus	2,432.13	2,551.59	2,374.01	2,659.40	2,568.52
Total Reserves and Surplus	2,432.13	2,551.59	2,374.01	2,659.40	2,568.52
Total Shareholders Funds	2,527.42	2,648.70	2,463.51	2,748.82	2,657.87
Minority Interest	67.24	152.95	154.65	133.50	50.21
NON-CURRENT LIABILITIES
Long Term Borrowings	603.91	1,806.51	1,551.32	1,637.71	2,627.00
Deferred Tax Liabilities [Net]	20.82	205.60	220.90	58.58	45.58
Other Long Term Liabilities	323.54	451.41	402.03	397.31	168.82
Long Term Provisions	63.95	52.24	16.55	25.19	14.45
Total Non-Current Liabilities	1,012.22	2,515.76	2,190.80	2,118.79	2,855.85
CURRENT LIABILITIES
Short Term Borrowings	1,228.78	1,339.02	944.39	1,393.96	700.48
Trade Payables	797.75	888.99	712.07	774.09	775.40
Other Current Liabilities	392.81	306.40	185.83	889.16	401.19
Short Term Provisions	125.52	127.83	57.01	46.66	14.93
Total Current Liabilities	2,544.86	2,662.24	1,899.30	3,103.87	1,891.99
Total Capital And Liabilities	6,151.73	7,979.66	6,708.41	8,104.98	7,455.91
ASSETS
NON-CURRENT ASSETS
Tangible Assets	1,388.69	1,114.74	738.38	1,048.90	1,030.81
Intangible Assets	281.41	1,155.12	1,155.50	969.11	795.84
Capital Work-In-Progress	148.06	99.54	322.01	204.50	278.74
Fixed Assets	2,083.04	2,722.90	2,514.17	2,798.19	2,641.53
Non-Current Investments	430.44	416.97	276.50	245.07	52.50
Deferred Tax Assets [Net]	198.58	172.88	123.52	70.12	95.82
Long Term Loans And Advances	38.97	68.27	62.46	57.54	11.55
Other Non-Current Assets	600.05	172.28	165.48	180.63	212.91
Total Non-Current Assets	3,779.62	4,930.93	4,224.82	4,313.16	3,941.02
CURRENT ASSETS
Current Investments	118.97	284.75	311.48	1,279.54	1,213.76
Inventories	782.54	874.16	552.02	732.80	613.14
Trade Receivables	931.69	987.18	882.18	995.91	1,032.97
Cash And Cash Equivalents	237.10	516.65	303.33	329.48	311.59
Short Term Loans And Advances	14.83	54.15	29.07	7.24	12.81
OtherCurrentAssets	286.98	331.83	405.51	446.86	330.64
Total Current Assets	2,372.11	3,048.72	2,483.59	3,791.82	3,514.89
Total Assets	6,151.73	7,979.66	6,708.41	8,104.98	7,455.91
OTHER ADDITIONAL INFORMATION
CONTINGENT LIABILITIES, COMMITMENTS
Contingent Liabilities	2,425.54	3,362.07	3,287.08	0.00	3,430.22
BONUS DETAILS
Bonus Equity Share Capital	1.25	1.25	1.25	1.25	1.25
NON-CURRENT INVESTMENTS
Non-Current Investments Quoted Market Value	0.98	11.13	10.09	30.23	0.00
Non-Current Investments Unquoted Book Value	0.06	0.06	0.06	236.31	73.98
CURRENT INVESTMENTS
Current Investments Quoted Market Value	0.00	154.29	311.48	1,279.54	0.00
Current Investments Unquoted Book Value	118.97	130.46	0.00	0.00	1,213.76